Hostelworld Group plc (HSWLF)
OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
Jul 31, 2025, 8:00 PM EDT
Marinus Pharmaceuticals Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 92.3 | 92 | 93.3 | 69.69 | 16.9 | 15.36 | Upgrade | |
Revenue Growth (YoY) | -1.67% | -1.39% | 33.88% | 312.34% | 10.00% | -80.95% | Upgrade |
Cost of Revenue | 21.1 | 19 | 19.7 | 40.42 | 34.29 | 16.76 | Upgrade |
Gross Profit | 71.2 | 73 | 73.6 | 29.27 | -17.39 | -1.4 | Upgrade |
Selling, General & Admin | 52.7 | 52.7 | 56.5 | 42.23 | 13.79 | 15.99 | Upgrade |
Other Operating Expenses | -1.3 | -1.3 | - | - | - | - | Upgrade |
Operating Expenses | 60.5 | 60.5 | 68.3 | 42.22 | 13.66 | 30.14 | Upgrade |
Operating Income | 10.7 | 12.5 | 5.3 | -12.95 | -31.06 | -31.53 | Upgrade |
Interest Expense | -0.1 | -0.4 | -2.5 | -4.27 | -3.45 | -0.25 | Upgrade |
Interest & Investment Income | 0.1 | 0.1 | - | - | - | 0.01 | Upgrade |
Earnings From Equity Investments | - | 0.1 | 0.1 | -0.21 | -0.23 | -0.37 | Upgrade |
Currency Exchange Gain (Loss) | -0.1 | -0.1 | -0.2 | - | - | 0.15 | Upgrade |
Other Non Operating Income (Expenses) | 0.2 | 0.1 | - | -0.03 | -0.06 | -0.57 | Upgrade |
EBT Excluding Unusual Items | 10.8 | 12.3 | 2.7 | -17.45 | -34.78 | -32.57 | Upgrade |
Merger & Restructuring Charges | - | - | -3.8 | -0.32 | -0.84 | -2.99 | Upgrade |
Gain (Loss) on Sale of Investments | -1.2 | -1.2 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.06 | Upgrade |
Asset Writedown | - | - | - | - | -0.37 | -15 | Upgrade |
Legal Settlements | - | - | - | -0.52 | - | - | Upgrade |
Other Unusual Items | - | - | - | 0.38 | -0.59 | - | Upgrade |
Pretax Income | 9.6 | 11.1 | -1.1 | -17.91 | -36.58 | -50.5 | Upgrade |
Income Tax Expense | 1.9 | 2 | -6.2 | -0.65 | -0.56 | -1.64 | Upgrade |
Net Income | 7.7 | 9.1 | 5.1 | -17.26 | -36.02 | -48.86 | Upgrade |
Net Income to Common | 7.7 | 9.1 | 5.1 | -17.26 | -36.02 | -48.86 | Upgrade |
Net Income Growth | -48.99% | 78.43% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 125 | 125 | 122 | 117 | 116 | 107 | Upgrade |
Shares Outstanding (Diluted) | 130 | 129 | 126 | 117 | 116 | 107 | Upgrade |
Shares Change (YoY) | 0.27% | 2.37% | 7.72% | 0.87% | 8.77% | 10.01% | Upgrade |
EPS (Basic) | 0.06 | 0.07 | 0.04 | -0.15 | -0.31 | -0.46 | Upgrade |
EPS (Diluted) | 0.06 | 0.07 | 0.04 | -0.15 | -0.31 | -0.46 | Upgrade |
EPS Growth | -49.49% | 72.24% | - | - | - | - | Upgrade |
Free Cash Flow | 16.3 | 20.2 | 17.3 | -0.95 | -13.83 | -11.1 | Upgrade |
Free Cash Flow Per Share | 0.13 | 0.16 | 0.14 | -0.01 | -0.12 | -0.10 | Upgrade |
Gross Margin | 77.14% | 79.35% | 78.89% | 42.00% | -102.91% | -9.08% | Upgrade |
Operating Margin | 11.59% | 13.59% | 5.68% | -18.58% | -183.75% | -205.25% | Upgrade |
Profit Margin | 8.34% | 9.89% | 5.47% | -24.77% | -213.10% | -318.00% | Upgrade |
Free Cash Flow Margin | 17.66% | 21.96% | 18.54% | -1.36% | -81.81% | -72.25% | Upgrade |
EBITDA | 15.9 | 18 | 14.1 | -12.77 | -30.5 | -30.59 | Upgrade |
EBITDA Margin | 17.23% | 19.56% | 15.11% | -18.32% | -180.44% | -199.13% | Upgrade |
D&A For EBITDA | 5.2 | 5.5 | 8.8 | 0.18 | 0.56 | 0.94 | Upgrade |
EBIT | 10.7 | 12.5 | 5.3 | -12.95 | -31.06 | -31.53 | Upgrade |
EBIT Margin | 11.59% | 13.59% | 5.68% | -18.58% | -183.75% | -205.25% | Upgrade |
Effective Tax Rate | 19.79% | 18.02% | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.